Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S, Kawahara K, Fujiwara Y, Ohnishi K, Pan C, Yano H, Hirosue A, Nagata M, Hirayama M, Sakata J, Nakashima H, Arita H, Yamana K, Gohara S, Nagao Y, Maeshiro M, Iwamoto A, Hirayama M, Yoshida R, Komohara Y, Nakayama H.
Kawaguchi S, et al. Among authors: yano h.
Cancer Immunol Immunother. 2022 Sep;71(9):2127-2139. doi: 10.1007/s00262-022-03149-w. Epub 2022 Jan 19.
Cancer Immunol Immunother. 2022.
PMID: 35044489
Free PMC article.